Table 1 Characteristics of patients with oropharyngeal cancer (n = 357) from the ARTSCAN trial as well as for study cohorts 1 (n = 232) and 2 (n = 203)
Patients with oropharyngeal cancer, n (%) | Study cohort 1, n (%) | Study cohort 2, n (%) | |
|---|---|---|---|
Age | |||
Median (min, max) | 58 (32, 86) | 57 (32, 86) | 57 (32, 86) |
<65 years | 275 (77.0) | 184 (79.3) | 160 (78.8) |
≥65 years | 82 (23.0) | 48 (20.7) | 43 (21.2) |
Sex | |||
Male | 267 (74.8) | 173 (74.6) | 154 (75.9) |
Female | 90 (25.2) | 59 (25.4) | 49 (24.1) |
Clinical stage | |||
I | 10 (2.8) | 8 (3.4) | 9 (4.4) |
II | 20 (5.6) | 16 (6.9) | 13 (6.4) |
III | 84 (23.5) | 54 (23.3) | 41 (20.2) |
IV | 243 (68.1) | 154 (66.4) | 140 (69.0) |
Surgery | |||
Yes | 166 (46.5) | 103 (44.4) | 106 (52.2) |
No | 191 (53.5) | 129 (55.6) | 97 (47.8) |
Conventional fractionation | 178 (49.9) | 117 (50.4) | 106 (52.2) |
Accelerated fractionation | 179 (50.1) | 115 (49.6) | 97 (47.8) |
Number of patients | n = 357 | n = 232 | n = 203 |